The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
A new variant of SARS-CoV-2 B.1.351 lineage (first found in South Africa) has been raising global concern due to its harboring of multiple mutations in the spike that potentially increase transmissibility and yield resistance to neutralizing antibodies. We here tested infectivity and neutralization...
Main Authors: | Yeong Jun Kim, Ui Soon Jang, Sandrine M. Soh, Joo-Youn Lee, Hye-Ra Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/4/633 |
Similar Items
-
The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice
by: Longbo Hu, et al.
Published: (2022-04-01) -
The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice
by: Cheng Zhang, et al.
Published: (2022-04-01) -
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
by: David R. Martinez, et al.
Published: (2021-07-01) -
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351
by: Chunyin Gu, et al.
Published: (2021-01-01) -
Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants
by: Rafael Bayarri-Olmos, et al.
Published: (2021-10-01)